The modified high-density survival assay is the useful tool to predict the effectiveness of fractionated radiation exposure

Yoshikazu Kuwahara, Miyuki Mori, Toshiyuki Oikawa, Tsutomu Shimura, Yosuke Ohtake, Shiro Mori, Yasuhito Ohkubo, Manabu Fukumoto

研究成果: Article査読

16 被引用数 (Scopus)

抄録

The high-density survival (HDS) assay was originally elaborated to assess cancer cell responses to therapeutic agents under the influence of intercellular communication. Here, we simplified the original HDS assay and studied its applicability for the detection of cellular radioresistance. We have recently defined clinically relevant radioresistant (CRR) cells, which continue to proliferate with daily exposure to 2 gray (Gy) of X-rays for more than 30 days in vitro. We established human CRR cell lines, HepG2-8960-R from HepG2, and SAS-R1 and-R2 from SAS, respectively. In an attempt to apply the HDS assay to detect radioresistance with clinical relevance, we simplified the original HDS assay by scoring the total number of surviving cells after exposure to X-rays. The modified HDS assay successfully detected radioresistance with clinical relevance. The modified HDS assay detected CRR phenotype, which is not always detectable by clonogenic assay. Therefore, we believe that the modified HDS assay presented in this study is a powerful tool to predict the effectiveness of fractionated radiotherapy against malignant tumors.

本文言語English
ページ(範囲)297-302
ページ数6
ジャーナルJournal of radiation research
51
3
DOI
出版ステータスPublished - 2010

ASJC Scopus subject areas

  • 放射線
  • 放射線学、核医学およびイメージング
  • 健康、毒物学および変異誘発

フィンガープリント

「The modified high-density survival assay is the useful tool to predict the effectiveness of fractionated radiation exposure」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル